PMC:7200337 / 107348-107621
Annnotations
2_test
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| 32505227-18018769-46575459 | 222-226 | 18018769 | denotes | 2007 |
| 32505227-18824060-46575460 | 243-247 | 18824060 | denotes | 2008 |
| 32505227-31351922-46575461 | 267-271 | 31351922 | denotes | 2019 |
| T97524 | 222-226 | 18018769 | denotes | 2007 |
| T59957 | 243-247 | 18824060 | denotes | 2008 |
| T65299 | 267-271 | 31351922 | denotes | 2019 |
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T41 | 110-117 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T613 | 4-12 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T90 | 29-35 | http://purl.obolibrary.org/obo/NCBITaxon_33208 | denotes | animal |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T69460 | 110-117 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
| T58496 | 210-213 | Chemical | denotes | Lin | http://purl.obolibrary.org/obo/CHEBI_32386 |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 3604 | 4-12 | Species | denotes | SARS-CoV | Tax:694009 |
| 3605 | 19-27 | Species | denotes | MERS-CoV | Tax:1335626 |
| 3609 | 160-163 | Chemical | denotes | nAb |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T639 | 0-273 | Sentence | denotes | For SARS-CoV-1 and MERS-CoV, animal studies and phase I clinical trials of potential vaccines targeting the S protein had encouraging results, with evidence of nAb induction and induction of cellular immunity (Lin et al., 2007, Martin et al., 2008, Modjarrad et al., 2019). |